Related Experiment Video
Updated: Dec 8, 2025

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Long Noncoding RNA (lncRNA) MT1JP Suppresses Hepatocellular Carcinoma (HCC) in vitro
Wenhui Mo1, Ying Dai1, Jianqing Chen1
1Department of Gastroenterology, Shidong Hospital of Shanghai, Shanghai 200433, People's Republic of China.
Introduction:
The purpose of this study was to evaluate the effects and mechanisms of the long noncoding RNA (lncRNA) MT1JP on hepatocellular carcinoma (HCC) in vitro.
Patients And Methods:
Thirty pairs of tumor and adjacent normal tissues were collected from HCC patients. Tissue pathology and MT1JP expression were evaluated by hematoxylin and eosin staining and in situ hybridization (ISH), respectively. The correlation between MT1JP and HCC prognosis was investigated. MTT assays, cloning, flow cytometry, transwell assays, and wound-healing assays were used to evaluate the effects of MT1JP on HCC cell lines. RT-qPCR and Western blot were used to measure the relative mRNA and protein expression levels.
Results:
The expression of MT1JP was downregulated in HCC tumor tissues compared with that in adjacent normal tissues, while the percent survival was significantly greater in the high MT1JP expression group than in the low MT1JP expression group (P=0.0238). In vitro, overexpression of MT1JP suppressed the proliferation, invasion, and migration, reduced colony cell number, increased cell apoptosis, and induced G1-phase cell cycle arrest in Bel-7402 and Huh-7 cells. Meanwhile, the mRNA and protein expression levels of RUNX3 and P21 were significantly upregulated, whereas those of MMP2 and MMP9 were significantly downregulated, in Bel-7402 and Huh-7 cells overexpressing MT1JP (all P<0.001).
Conclusion:
LncRNA MT1JP may function as a tumor suppressor in HCC. Overexpression of MT1JP suppressed HCC cell biological activities through the regulation of RUNX3.
Insights
Long noncoding RNA MT1JP acts as a tumor suppressor in hepatocellular carcinoma (HCC). Its overexpression inhibits HCC cell proliferation and invasion, suggesting therapeutic potential for HCC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hepatocellular carcinoma (HCC) is a major global health concern.
- Long noncoding RNAs (lncRNAs) play critical roles in various cancers, including HCC.
- The specific role of lncRNA MT1JP in HCC remains largely unexplored.
Purpose of the Study:
- To investigate the expression, function, and mechanism of lncRNA MT1JP in hepatocellular carcinoma (HCC).
- To evaluate the potential of MT1JP as a therapeutic target for HCC.
Main Methods:
- Analysis of MT1JP expression in HCC tissues and adjacent normal tissues using in situ hybridization (ISH).
- In vitro assays including MTT, cloning, flow cytometry, transwell, and wound-healing assays to assess HCC cell behavior.
- RT-qPCR and Western blot to determine mRNA and protein expression levels of key genes.
Main Results:
- MT1JP was significantly downregulated in HCC tissues and associated with poorer prognosis.
- Overexpression of MT1JP inhibited HCC cell proliferation, invasion, and migration, while promoting apoptosis and cell cycle arrest.
- MT1JP overexpression upregulated RUNX3 and P21, and downregulated MMP2 and MMP9 expression.
Conclusions:
- LncRNA MT1JP functions as a tumor suppressor in HCC.
- MT1JP suppresses HCC cell proliferation and invasion by regulating RUNX3.
- MT1JP holds potential as a novel therapeutic target for HCC treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Non-LTR Retrotransposons
MicroRNAs
MicroRNAs
Types of RNA
RNA Performs Diverse...